←
NervGen640 posts
NervGen avatar

NervGen

@NervgenP

Restoring Life's Potential by Enabling the Nervous System to Repair Itself

◷ Joined May 2019▧ 227 Photos and videos
NervGen avatar
NervGen@NervgenP·13h

Today, we announced the appointment of Sam Jackson, MD, MBA, as Chief Medical Officer. Dr. Jackson brings expertise in innovative neuroscience trial design and experience advancing therapies through pivotal development and FDA approval. nervgen.com/nervgen-appoints… #SCI #RESTORE

Post attachmentPost attachment
NervGen avatar
NervGen@NervgenP·Nov 16

Our recent clinical and regulatory milestones mark a significant step forward for NVG-291 and our mission to transform the lives of individuals living with spinal cord injury by enabling the nervous system to repair itself. Read more: nervgen.com/nervgen-reports-… #SCI #RESTORE

Post attachmentPost attachmentPost attachment
NervGen avatar
NervGen@NervgenP·Nov 12

Today, we announced that the U.S. FDA has granted Breakthrough Therapy designation to NVG-291 for the treatment of chronic traumatic cervical motor-incomplete spinal cord injury (SCI). Read more: nervgen.com/nervgen-receives…

Post attachmentPost attachment
NervGen avatar
NervGen@NervgenP·Nov 9

It was wonderful bringing together investigators and site staff for RESTORE, our Phase 3 study evaluating NVG-291 in chronic cervical spinal cord injury. Thank you for the work that begins long before a participant's first visit and continues throughout the study. #SCI #RESTORE

0:22
NervGen avatar
NervGen@NervgenP·Sep 9

On September 30th, NVG-291 will be in focus at NervGen’s inaugural R&D Day. Four leading experts in SCI clinical care, outcome assessment, translational research and community advocacy will join NervGen management for an in-depth program review and Q&A. Register: edge.media-server.com/mmc/p/…

Post attachment
NervGen avatar
NervGen@NervgenP·Sep 8

Did you know? A recent analysis of structured community feedback led by NASCIC and published in Spinal Cord found that 87% of participants with traumatic cervical SCI linked potential treatment success to functional tasks—not muscle grading alone. Learn more: doi.org/10.1038/s41393-026-0…

Post attachmentPost attachmentPost attachment
NervGen avatar
NervGen@NervgenP·Sep 5

On #WorldSCIDay, we join @iscosmeetings in marking 10 years of turning awareness into action on SCI prevention. Individuals living with SCI can help guide the next decade by sharing their perspectives at the free virtual Sept. 29 SCI PFDD meeting: scipfdd.org/register

0:07
NervGen avatar
NervGen@NervgenP·Sep 2

More than 15 million people worldwide live with SCI. Behind every number is a person with individual experiences, priorities and goals. This #SCIAwarenessMonth, join the conversation and register for the Patient-Focused Drug Development meeting on SCI: scipfdd.org

Post attachment
NervGen avatar
NervGen@NervgenP·Sep 1

September is #SCIAwarenessMonth. Through the month, we'll highlight the priorities of individuals living with SCI and the science driving our work to enable the nervous system to repair itself — including the Sept. 29 @SCIPFDD Meeting. Register: scipfdd.org/register

NervGen avatar
NervGen@NervgenP·Jun 30

NervGen has a new website! NervGen's redesigned website is live — a clearer look at our science, our pipeline, and our mission to transform the lives of individuals living with spinal cord injury and nervous system damage. Take a look at nervgen.com